Mobile
Search
Advanced search
Multi-criteria search
Who are we ?
Log in
Sign up
Français
English
Kusajili – Clinical trials directory
Send this study to a contact
1
Your personal information
Your name
Your e-mail
Send me a copy
2
Your recipient's information
The name of your contact
Your contact email
3
Your message
Votre message
A 66-Week Extension to: A Phase IIb, Randomized, Placebo-Controlled, Dose-Range Finding, Clinical Trial to Study the Safety and Efficacy of MK-3102 in Patients with Type 2 Diabetes Mellitus and Inadequate Glycemic Control https://kusajili.com:443/Trial/ckpGyJPM6UmKkfm2jmr7uQ%24a-66-week-extension-to-a-phase-iib-randomized-placebo-controlled-dose-range-finding-clinical-trial-to-study-the-safety-and-effi
I have read and accept the terms of use of the site and the Privacy Policy
Send your message